Medtronic, Inc. (MDT) Managment Meeting Offers Encouraging Insight - Credit Suisse

March 16, 2021 7:27 AM EDT Send to a Friend
Credit Suisse analyst Matt Miksic reiterated an Outperform rating and $130.00 price target on Medtronic, Inc. (NYSE: MDT) after meeting ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login